tailieunhanh - Pharmaceutical Substances Syntheses, Patents, Applications - Part 118

Pharmaceutical Substances Syntheses, Patents, Applications - Part 118. Reference containing a collection of 2267 active pharmaceutical ingredients, including those launched recently. Listed alphabetically according to their INNs and established a link between INNs, structure, synthesis and production processes, patent and literature situation, medical use, and trade names. For pharmacists and researchers | Levorphanol L 1171 F Adepal Wyeth-Lederle - numerous combination J Microlut Nihon Schering GB comb. with ethynylestradiol Microval Wyeth-Lederle - I comb with ethynylestradiol Minidril Wyeth-Lederle -comb. with ethynylestradiol Trinordiol Wyeth-Lederle -comb. with ethynylestradiol Microval Wyeth preparations Binordiol Wyeth -comb. Bivlar Schering -comb. Egogyn Schering -comb. Evanor D Wyeth -comb. Microgynon Schering -comb. Microlut Schering Novogyn Schering -comb. Micro 30 Wyeth Norgeston Nihon Schering USA Alesse Wyeth-Ayerst -comb. Levien Berlex -comb. Nordette Wyeth-Ayerst -comb. Tri-Levlen Berlex -comb. Mirena Schering Norgeston Schering Ovranet Wyeth -comb. Trigynon Schering -comb. Trinordiol Wyeth -comb. Triphasil Wyeth-Ayerst -comb. Levorphanol ATC N02 Use analgesic RN 77-07-6 MF C17HMNO MW EINECS 201-002-6 LD50 41 mg kg M . 285 mg kg M . 150 mg kg R . CN 17-methylmorphinan-3-ol tartrate 1 1 . RN 125-72-4 MF C17H23NO C4H6O6 MW EINECS 204-753-8 LD50 32 mg kg M . 285 mg kg M . 27 mg kg R . 150 mg kg R . 46 mg kg dog . COOH CN ch3coonh4 1 -cyclohexenyl- acetanitrile I cyclo- cyanoocetic hexonone acid ----------------- 4-methoxyphenyl acetyl chloride N- 2- 1 -cyclahexenyl -ethyl -4-methoxy-phenylocetamide II 2- l-cyclo-hexenyl -ethylamine 1 - 4-methoxybenzyl -3 4 5 6 7 8-hexahydro-isoquinoline 1 - 4-methoxybenzyl -1 2 3 4 5 6 7 8-octa-hydroquinoline 111 1172 L Levothyroxine -3-hydroxy- N-methylmorphinon IV H2 Roney Ni Ill HCHO -------------- 1 - 4-methoxybenzyl - 2-methyl-1 2 3 4 5 6 7 8-octohydroisoquinoline tartoric ocid -------------- Reference s Ehrhart Ruschig I 130-131. Schnider O. Hellerbach J. Helv. Chim. Acta HCACAV 33 1437 1950 . Schnider O. Griissner A. Helv. Chim. Acta HCACAV 34 2211 1951 . Formulation s amp. 2 mg ml tabl. 2 mg as tartrate Trade Name s D Dromoran Roche wfm GB Dromoran Roche wfm USA Levo-Dromoran Roche Levothyroxine ATC H03AA01 Use thyroid hormone RN 51-48-9 MF CuHhLNCX MW EINECS 200-101-1